We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.7B
AUM Growth
-$32.1M
(-0.06%)
Cap. Flow
-$1.71B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
1,757
New
32
Increased
448
Reduced
504
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$159M |
| 2 |
Uber
UBER
|
+$127M |
| 3 |
Broadcom
AVGO
|
+$118M |
| 4 |
Humana
HUM
|
+$89.3M |
| 5 |
KKR & Co
KKR
|
+$71.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$171M |
| 2 |
Apple
AAPL
|
+$145M |
| 3 |
Merck
MRK
|
+$107M |
| 4 |
Nike
NKE
|
+$95.7M |
| 5 |
Mastercard
MA
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.24% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.51% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Phillips 66
PSX
$83.3B
| $18.3M | 0.03% |
129,790
+2,330
| +2% | +$345K |
|
327
argenx
ARGX
$55.6B
| $18.2M | 0.03% |
42,207
-3,702
| -8% | -$1.42M |
|
328
Conagra Brands
CAG
$7.29B
| $18M | 0.03% |
634,308
+55,790
| +10% | +$1.68M |
|
329
Occidental Petroleum
OXY
$54.6B
| $17.9M | 0.03% |
284,192
-7,355
| -3% | -$472K |
|
330
Alnylam Pharmaceuticals
ALNY
$37.2B
| $17.9M | 0.03% |
73,473
-8,297
| -10% | -$1.31M |
|
331
Capital One
COF
$127B
| $17.6M | 0.03% |
127,458
-3,585
| -3% | -$503K |
|
332
Weyerhaeuser
WY
$17.2B
| $17.5M | 0.03% |
615,222
+67,200
| +12% | +$2.08M |
|
333
Avantor
AVTR
$8.03B
| $17.4M | 0.03% |
822,081
+256,589
| +45% | +$6.18M |
|
334
Travelers Companies
TRV
$81.4B
| $17.4M | 0.03% |
85,547
-1,410
| -2% | -$303K |
|
335
Ares Management
ARES
$28.8B
| $17.2M | 0.03% |
129,408
+35,370
| +38% | +$4.83M |
|
336
IDEAYA Biosciences
IDYA
$3.54B
| $17M | 0.03% |
483,714
-4,656
| -1% | -$184K |
|
337
Fidelity National Information Services
FIS
$22.3B
| $16.9M | 0.03% |
224,758
-18,575
| -8% | -$1.38M |
|
338
US Bancorp
USB
$98.9B
| $16.8M | 0.03% |
424,102
+33,120
| +8% | +$1.35M |
|
339
Inspire Medical Systems
INSP
$1.47B
| $16.8M | 0.03% |
125,286
-38,350
| -23% | -$7.26M |
|
340
DTE Energy
DTE
$30.6B
| $16.7M | 0.03% |
150,644
-3,380
| -2% | -$378K |
|
341
PTC
PTC
$14.5B
| $16.7M | 0.03% |
91,921
-1,930
| -2% | -$345K |
|
342
Idexx Laboratories
IDXX
$43.9B
| $16.6M | 0.03% |
34,006
-5,609
| -14% | -$2.82M |
|
343
Arch Capital
ACGL
$36.3B
| $16.6M | 0.03% |
164,099
-5,450
| -3% | -$530K |
|
344
Roblox
RBLX
$34.7B
| $16.5M | 0.03% |
443,126
+107,182
| +32% | +$3.82M |
|
345
ResMed
RMD
$29.5B
| $16.4M | 0.03% |
85,710
+13,324
| +18% | +$2.7M |
|
346
Twist Bioscience
TWST
$5.39B
| $16.3M | 0.03% |
331,373
+141,557
| +75% | +$5.77M |
|
347
Coupang
CPNG
$28.6B
| $16.3M | 0.03% |
775,840
-35,132
| -4% | -$762K |
|
348
Cboe Global Markets
CBOE
$30.2B
| $16.2M | 0.03% |
95,306
-6,010
| -6% | -$1.07M |
|
349
Tarsus Pharmaceuticals
TARS
$2.62B
| $16.2M | 0.03% |
594,325
-133,566
| -18% | -$4.49M |
|
350
M&T Bank
MTB
$36B
| $16.1M | 0.03% |
106,296
-6,415
| -6% | -$937K |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Ensign Peak Advisors held 1,757 positions worth $54.7B, down 0.06% from $54.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ensign Peak Advisors withdrew a net $1.71B in Q2 2024, closing 45 positions and reducing 504 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $63.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ensign Peak Advisors opened a new position in JFrog worth $30.1M.
- Ensign Peak Advisors's largest Q2 2024 buy was JFrog: 801,556 shares worth $30.1M.
- Ensign Peak Advisors added most to GE Aerospace in Q2 2024, an estimated $159M increase.
- Ensign Peak Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $171M.
- Ensign Peak Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $63.5M.
- Ensign Peak Advisors's ten largest holdings make up 33% of its $54.7B portfolio in Q2 2024.
- Ensign Peak Advisors opened 32 new positions and closed 45 in Q2 2024.
- Ensign Peak Advisors's portfolio value fell 0.06% quarter-over-quarter to $54.7B.
Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.